About MAXIM BIOMEDICAL, INC
MaximBio is a U.S.-based company specializing in the development and manufacturing of lateral flow, molecular, and immunoassay diagnostics, offering end-to-end services from concept to commercialization. They operate an FDA-registered, ISO 13485-certified facility in Maryland and have over 20 years of experience in IVD development.
End-to-end diagnostic developmentManufacturing of lateral flow, ELISA, and custom immunoassaysAssay development including antibody screening, selection, and conjugationCustom reagent and buffer formulationProduct design, engineering, and system integrationPrototype and pilot-scale productionClinical and regulatory strategy supportScalable production with automated lines and controlled environments
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Defense | $54.6M | |
| OVER THE COUNTER (OTC) COVID-19 TESTS | Department of Health and Human Services | $49.5M | |
| Federal contract award | Department of Health and Human Services | $2.7M | |
| Federal contract award | Department of Health and Human Services | $20K | |
| Federal contract award | Department of Health and Human Services | $5.3M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MAXIM BIOMEDICAL, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.